Qi Biodesign

Private

BeijingHealthcare & Life Scienceshttps://www.qi-biodesign.com/

Last Round

Series A

Dec 6, 2024

Total Funding Raised

$75M

Company Overview

Qi Biodesign is a biotechnology company that develops and applies next-generation genome editing technologies for agricultural innovation and plant breeding.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

genome editinggenome editing platformagricultural biotechnologyag biotechgene-edited cropscrop breedingprecision breedingplant geneticsprime editorsbase editorstrait discoverysynthetic biologytechnology licensingagritechcontract research organizationCRO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Qi Biodesign Comps

Public and private peers based on sector, stage, and business model.

Qi Biodesign comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Qi Biodesign Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Dec 6, 2024
Pre Seed	Apr 20, 2023
Seed	Mar 1, 2022

View all Funding Rounds

Qi Biodesign Investors

Notable investors and investment history

Qi Biodesign investors
Investor	Rounds
CD Capital Asset Management	Pre Seed
Zhongke Chuangxing	Seed
Shang Capital	Pre Seed, Seed
Source Code Capital	Pre Seed, Seed
MingCapital	Series A
Gaorong Capital	Pre Seed, Seed
CD Capital	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 6, 2024
$41M round with participation from CD Capital and MingCapital.
Apr 20, 2023
$15M round led by CD Capital Asset Management.

View all signals

Qi Biodesign Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Qi Biodesign Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Qi Biodesign's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing

Year Founded2021

Last FundingDec 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.